Homepage

Gene Bio Medical(GBM) is a Canadian biotechnology company dedicated to the research, development, manufacturing, and commercialization of innovative diagnostic technologies that improve human health and strengthen global disease response capabilities. Our mission is to deliver high-quality, accessible, and cost-effective diagnostic solutions that empower healthcare providers, patients, and communities worldwide.

Driven by a vision to transform healthcare through scientific innovation, Gene Bio Medical(GBM) focuses on advancing molecular diagnostics, rapid point-of-care testing, AI-enabled diagnostic platforms, digital health solutions, and scalable biomanufacturing technologies. By integrating artificial intelligence, advanced analytics, and next-generation diagnostic tools, we aim to improve the speed, accuracy, and accessibility of healthcare decision-making.

Founded by a multidisciplinary team of scientists, healthcare professionals, and business leaders, Gene Bio Medical(GBM) has grown into a recognized innovator in the diagnostics industry. The company develops, manufactures, and commercializes its own portfolio of diagnostic products while collaborating with academic institutions, healthcare organizations, industry partners, and government agencies to accelerate the translation of scientific discoveries into real-world healthcare solutions.

Through innovation, strategic partnerships, and a commitment to strengthening Canadian biomanufacturing, Gene Bio Medical(GBM) is building the next generation of AI-enabled diagnostic technologies for global markets while contributing to a more resilient and sustainable healthcare ecosystem.

Gene Bio Medical(GBM)  provides a comprehensive range of services spanning molecular diagnostics, genomics, proteomics, bioinformatics, drug testing, AI-enabled healthcare solutions, precision health technologies, and translational research and development. Our mission is to deliver innovative, accessible, and cost-effective solutions that improve health outcomes and enhance quality of life for people worldwide.

Through scientific excellence and continuous innovation, we develop high-performance diagnostic technologies that combine accuracy, reliability, scalability, and affordability. Our products and services are supported by advanced molecular technologies, artificial intelligence, rigorous quality systems, and evidence-based research, enabling healthcare providers and patients to make faster and more informed decisions.

Gene Bio Medical(GBM) is expanding its advanced biomanufacturing capabilities by integrating automation, artificial intelligence, digital health technologies, microfluidics, and next-generation diagnostic platforms into its development and manufacturing processes. This integrated approach enables the efficient, scalable, and cost-effective production of innovative healthcare solutions for global markets.

Working closely with academic institutions, healthcare organizations, industry partners, and government agencies, we accelerate the translation of scientific discoveries into commercially viable products that address real-world healthcare challenges. Our collaborative innovation model strengthens healthcare resilience while advancing Canada’s position as a leader in biotechnology and biomanufacturing.

As we continue to expand internationally, our vision is to become a global leader in AI-enabled diagnostics, precision health, and advanced biomanufacturing. Through strategic partnerships, scientific innovation, and commercialization excellence, we are accelerating the transformation of healthcare and improving lives around the world.

News

Disclaimer: Not all medical devices are licensed in accordance with Canadian law. Health Canada Authorized Manufacturer’s Company ID: 167878

Avertissement: Tous les dispositifs médicaux ne sont pas autorisés conformément à la loi canadienne. Numéro d’identification de l’entreprise du fabricant autorisé par Santé Canada : 167878.